Gulf International Bank UK Ltd Cuts Stake in IQVIA Holdings Inc. (NYSE:IQV)

Gulf International Bank UK Ltd decreased its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 27.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,659 shares of the medical research company's stock after selling 5,562 shares during the period. Gulf International Bank UK Ltd's holdings in IQVIA were worth $3,473,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. PGGM Investments raised its holdings in shares of IQVIA by 55.8% in the 2nd quarter. PGGM Investments now owns 12,073 shares of the medical research company's stock worth $2,553,000 after acquiring an additional 4,326 shares during the last quarter. SG Americas Securities LLC boosted its position in shares of IQVIA by 80.1% during the first quarter. SG Americas Securities LLC now owns 45,787 shares of the medical research company's stock valued at $11,579,000 after buying an additional 20,369 shares during the last quarter. Quadrature Capital Ltd purchased a new stake in IQVIA in the 1st quarter valued at $3,365,000. Raymond James & Associates lifted its position in shares of IQVIA by 0.7% during the second quarter. Raymond James & Associates now owns 800,374 shares of the medical research company's stock valued at $169,231,000 after purchasing an additional 5,417 shares in the last quarter. Finally, UniSuper Management Pty Ltd grew its holdings in shares of IQVIA by 253.0% in the first quarter. UniSuper Management Pty Ltd now owns 6,029 shares of the medical research company's stock valued at $1,525,000 after acquiring an additional 4,321 shares in the last quarter. Institutional investors and hedge funds own 89.62% of the company's stock.

Insider Activity

In other news, insider Eric Sherbet sold 1,300 shares of the firm's stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total value of $320,229.00. Following the completion of the transaction, the insider now owns 19,536 shares in the company, valued at $4,812,302.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.60% of the company's stock.

Analyst Ratings Changes

A number of research firms recently issued reports on IQV. Morgan Stanley lowered their price objective on shares of IQVIA from $280.00 to $265.00 and set an "overweight" rating on the stock in a research report on Monday. Argus raised IQVIA to a "strong-buy" rating in a report on Wednesday, July 31st. Robert W. Baird lowered their target price on IQVIA from $256.00 to $223.00 and set a "neutral" rating on the stock in a research note on Friday, November 1st. JPMorgan Chase & Co. cut their price target on IQVIA from $279.00 to $240.00 and set an "overweight" rating for the company in a research note on Tuesday. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $270.00 price objective on shares of IQVIA in a report on Friday, November 1st. Four analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, IQVIA currently has an average rating of "Moderate Buy" and an average price target of $259.13.

IQVIA Price Performance

IQV traded up $8.32 during trading on Wednesday, reaching $221.19. The stock had a trading volume of 2,064,229 shares, compared to its average volume of 1,096,835. The stock has a market cap of $40.15 billion, a PE ratio of 29.04, a PEG ratio of 2.15 and a beta of 1.51. The business has a 50-day moving average of $232.84 and a 200-day moving average of $229.54. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. IQVIA Holdings Inc. has a one year low of $190.20 and a one year high of $261.73.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.